StaniPharm Overview

  • Founded
  • 2009
  • Status
  • Private
  • Employees
  • 11
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 4

StaniPharm General Information


Developer of drug substances and differentiated drug products designed to offer improved clinical performances over existing formulation. The company's products use Supercritical Fluid (SCF) technology and formulation techniques, enabling life science industries to efficiently move their product along the development path and get high-quality results using cost-effective supercritical fluid technologies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 5 rue Jacques Monod
  • BP 80010
  • 54250 Champigneulles
  • France
+33 03 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

StaniPharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 00000 Completed Generating Revenue
1. Early Stage VC 15-Jun-2010 00000 00000 Completed Generating Revenue
To view StaniPharm’s complete valuation and funding history, request access »

StaniPharm Executive Team (3)

Name Title Board Seat Contact Info
Frantz Deschamps Co-Founder, Chief Executive Officer, Chairman & President
Fabrice Leboeuf Project Manager & Co-Founder
Jennifer Jung Co-Founder
To view StaniPharm’s complete executive team members history, request access »

StaniPharm Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

StaniPharm Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ADER Investissements Venture Capital Minority 000 0000 000000 0
Aqua Asset Management Asset Manager Minority 000 0000 000000 0
ILP Sadepar Gestion PE/Buyout Minority 000 0000 000000 0
Incubateur Lorrain Accelerator/Incubator Minority 000 0000 000000 0
To view StaniPharm’s complete investors history, request access »